Arbutus Biopharma Corp (ABUS)

EBITDA Margin

84.29%

TTM · Period ending:

ABUS logo

ABUS EBITDA Margin

Latest reported84.29%
ABUS EBITDA Margin (-632.58% → 84.29%)
High-resolution chart · PNG

ABUS ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-234.6162%
-1,108.4589%
-391.3015%
-158.5356%
-651.9567%
-835.3486%
-2,699.1016%
-999.2034%
-994.8131%
-32,538.2667%
-308.4348%
-216.2867%
-74.6177%
241.0514%
-55.5523%
-51.7311%
-48.8814%
-74.9742%
19.1589%
154.15%
9.8546%
-147.118%
-1,016.0165%
-434.9543%
-363.4636%
-532.4407%
-602.2907%
-632.5786%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.